JDRF Issues Statement on Insulin Price Hikes
July 22, 2019
July 22, 2019
NEW YORK, July 22 -- JDRF, a charitable 501(c)(3) organization dedicated to funding type 1 diabetes research, issued the following statement by President and CEO Aaron J. Kowalski on Sen. Jeanne Shaheen's bill to rollback over a decade of insulin price hikes:
"No one should suffer or die because they cannot access insulin. We are very grateful for Senators Shaheen, Collins, Carper, and Cramer for introducing this important piece of legislation, which would treat insulin like th . . .
"No one should suffer or die because they cannot access insulin. We are very grateful for Senators Shaheen, Collins, Carper, and Cramer for introducing this important piece of legislation, which would treat insulin like th . . .